BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2891634)

  • 1. Lack of correlation of ultrasonographically determined ovarian size with age, ponderal index, and hormonal factors in 45 patients with polycystic ovarian disease.
    Futterweit W; Yeh HC; Thornton JC
    Int J Fertil; 1987; 32(6):456-9. PubMed ID: 2891634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The androgenic profile of women with non-insulin-dependent diabetes mellitus.
    Tok EC; Ertunc D; Evruke C; Dilek S
    J Reprod Med; 2004 Sep; 49(9):746-52. PubMed ID: 15493567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian stromal hypertrophy in polycystic ovary syndrome.
    Kaleli S; Erel CT; Oral E; Elter K; Akman C; Colgar U
    J Reprod Med; 1998 Oct; 43(10):893-7. PubMed ID: 9800673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T; Dehghan-Kooshkghazi M
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
    Timpatanapong P; Rojanasakul A
    J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycystic ovaries: specific disease picture or nonspecific symptom?].
    Moltz L; Sörensen R; Römmler A; Schwartz U; Hammerstein J
    Geburtshilfe Frauenheilkd; 1985 Feb; 45(2):107-14. PubMed ID: 3920114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of bromocryptin in polycystic ovary syndrome].
    Fuhrer J; Cheviakoff S; Rubio V
    Rev Chil Obstet Ginecol; 1989; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
    Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
    Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone profile & polycystic ovaries in acne vulgaris.
    Jebraili R; Kaur S; Kanwar AJ; Kataria S; Dash RJ
    Indian J Med Res; 1994 Aug; 100():73-6. PubMed ID: 7927560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
    Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
    Shterev AD; Dokumov SI
    Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary polycystic ovary syndrome in a premenarchal girl. A case report.
    Rao JK; Chihal HJ; Johnson CM
    J Reprod Med; 1985 Apr; 30(4):361-5. PubMed ID: 3925138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
    Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
    J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperthecosis ovarii--a tumor-like change in androgenized females].
    Schwartz U; Moltz L; Pickartz H; Sörensen R; Römmler A
    Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):391-7. PubMed ID: 3091442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin levels in the polycystic ovary syndrome.
    Milewicz A
    J Reprod Med; 1984 Mar; 29(3):193-6. PubMed ID: 6233421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
    Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
    Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.